CD274 and neoplasm: In particular, the immune checkpoint blockade of the programmed death receptor-1 (PD-1)/PD ligand 1 (PD-L1) pathway, combined with the VEGF-pathway blockade, can enhance both anti-tumor immunity and a structural normalization of tumor vessels [116,118,119].